BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16084947)

  • 1. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma.
    Xie D; Sham JS; Zeng WF; Lin HL; Bi J; Che LH; Hu L; Zeng YX; Guan XY
    Hum Pathol; 2005 Jul; 36(7):777-83. PubMed ID: 16084947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of AIB1 in nasopharyngeal carcinomas correlates closely with advanced tumor stage.
    Liu MZ; Xie D; Mai SJ; Tong ZT; Shao JY; Fu YS; Xia WJ; Kung HF; Guan XY; Zeng YX
    Am J Clin Pathol; 2008 May; 129(5):728-34. PubMed ID: 18426732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.
    He LR; Liu MZ; Li BK; Rao HL; Deng HX; Guan XY; Zeng YX; Xie D
    Cancer Sci; 2009 Sep; 100(9):1591-6. PubMed ID: 19552757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas.
    Xu FP; Xie D; Wen JM; Wu HX; Liu YD; Bi J; Lv ZL; Zeng YX; Guan XY
    Cancer Lett; 2007 Jan; 245(1-2):69-74. PubMed ID: 16458427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
    Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
    Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and amplification of steroid receptor coactivator-3 gene in colorectal carcinoma and its clinicopathological significance].
    Zeng SD; Xie D; Lin F; Wang CX; Tao Y; Zhang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jan; 8(1):67-70. PubMed ID: 16149006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance and characteristics of chromosomal abnormalities in patients with microsatellite and chromosome stable colorectal carcinoma].
    Xie D; Wu HX; Liu YD; Zeng SD; Lin F
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):11-5. PubMed ID: 17403304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
    Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C
    Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of AIB1 protein in epithelial ovarian cancer cells and its impact on apoptosis].
    Han XY; Chen Y; Hou MM; Zhang J; Yang KX; Chen YY; Qie MR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):619-22, 634. PubMed ID: 18798508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma.
    Henke RT; Haddad BR; Kim SE; Rone JD; Mani A; Jessup JM; Wellstein A; Maitra A; Riegel AT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6134-42. PubMed ID: 15448000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.
    Torres-Arzayus MI; Font de Mora J; Yuan J; Vazquez F; Bronson R; Rue M; Sellers WR; Brown M
    Cancer Cell; 2004 Sep; 6(3):263-74. PubMed ID: 15380517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma?
    Sory A; Minamoto T; Ohta T; Yamashita K; Sawaguchi K; Mai M; Misiuna P
    Eur J Surg; 1997 Sep; 163(9):685-92. PubMed ID: 9311476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.
    Buglioni S; D'Agnano I; Vasselli S; Perrone Donnorso R; D'Angelo C; Brenna A; Benevolo M; Cosimelli M; Zupi G; Mottolese M
    Am J Clin Pathol; 2001 Sep; 116(3):360-8. PubMed ID: 11554164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological significance of expression and amplification of P21-activated kinase 1 gene in colorectal carcinoma].
    Li ZX; Zeng SD; Liu YD; Liao YJ; Hua WF; Lin F; Xie D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):185-8. PubMed ID: 19296259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma.
    Sun XF; Ekberg H; Zhang H; Carstensen JM; Nordenskjöld B
    APMIS; 1998 Jun; 106(6):657-64. PubMed ID: 9725799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
    Dihge L; Bendahl PO; Grabau D; Isola J; Lövgren K; Rydén L; Fernö M
    Breast Cancer Res Treat; 2008 May; 109(2):255-62. PubMed ID: 17636398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.